Related Experiment Video

Updated: Jun 2, 2026

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

Congenital plaque-type glomuvenous malformation associated with chylous ascites

Maria Tejedor1, Ana Martín-Santiago, Cristina Gómez

  • 1Department of Pediatrics, Hospital Universitario Son Dureta, Mallorca, Spain. mtejedormestre@yahoo.es

Pediatric Dermatology
|April 22, 2011
PubMed

Insights

Congenital plaque-type glomuvenous malformation (GVM), a rare vascular disorder, can present with prenatal chylous ascites. This complication may stem from the shared developmental origins of GVM and lymphatic vessels.

Area of Science:

  • Vascular Biology
  • Genetics
  • Developmental Biology

Background:

  • Congenital plaque-type glomuvenous malformation (GVM) is a rare vascular anomaly.
  • GVM arises from loss-of-function mutations in the glomulin gene.
  • Glomulin mutations affect vascular development and integrity.

Observation:

  • A rare case of congenital plaque-type GVM in a newborn is presented.
  • This GVM was associated with a significant prenatal complication: chylous ascites.
  • Chylous ascites involves the accumulation of lymphatic fluid in the abdominal cavity.

Findings:

  • The study highlights an unusual prenatal complication of glomuvenous malformations.
  • A potential link between GVM and chylous ascites is suggested.
  • The common mesenchymal origin of GVM and lymphatic vessels is a key factor.

Implications:

  • Understanding the shared developmental pathways can elucidate GVM complications.
  • Glomulin expression in fetal vascular smooth muscle cells may play a role.
  • This case expands the known clinical spectrum of glomuvenous malformations.

More Related Videos

A Patient-Derived Xenograft Model for Venous Malformation06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

Related Concept Videos

Ascites01:19

Ascites

DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...